For most patients, these effects are transient and diminish as the body adjusts to treatment
The high cost of GLP-1 plus the risk of inappropriate or unnecessary prescriptions requires GLP-1 coverage to be a structured process with checks and balances to ensure necessary and effective prescribing and avoid side effects that can result in early discontinuation
The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity
Again, this step-up gives your body time to get used to the medication
Designed solely for parenteral use (drug administration by intravenous, intramuscular, or subcutaneous injection) following the addition of
Stine ZE, Walton ZE, Altman BJ, Hsieh AL, and Dang CV